chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling of my tongue and face. Could still breath so didn't go to emergency room. Fully went away after about 4 hours. Left arm could barely lift through the next day. Achy sinuses feeling through the next day.
Light headed; Body aches; Malaise; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 13:45 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome. Concomitant medications included sertraline hydrochloride (ZOLOFT), celecoxib (CELEBREX), fexofenadine hydrochloride (ALLEGRA), hydroxychloroquine sulfate (PLAQUENIL) and probiotic, all from unknown dates and for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208 ) via an unspecified route of administration in the left arm on 09Mar2021 at 16:45 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies.  The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient experienced light headed, body aches, malaise, headache and nausea. The patient received tylenol as the treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event light headed, body aches, malaise, headache and nausea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient tested positive for COVID-19 on 8/6/21 despite having received COVID-19 vaccines on 1/14/21 and 2/11/21
I got my 2nd shot on 8/21/21. I went floating on the spring river in the sun for 6 hours and broke out in a terrible rash in my face, chest, and shoulder s that is still present a week later.
This case was reported by a consumer via interactive digital media and described the occurrence of ventricular tachycardia in a 65-year-old female patient who received Influenza vaccine Quadrivalent unspecified season for prophylaxis. Concurrent medical conditions included migraine. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On 11th August 2018, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced ventricular tachycardia (serious criteria GSK medically significant), heart attack (serious criteria GSK medically significant), near death experience (serious criteria GSK medically significant), asystole (serious criteria GSK medically significant) and allergy. On an unknown date, the outcome of the ventricular tachycardia, heart attack, near death experience, asystole and allergy were unknown. It was unknown if the reporter considered the ventricular tachycardia, heart attack, near death experience, asystole and allergy to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at the vaccination was not reported. The patient felt allergic to the flu shot and was felt the vaccine killed her due to which the patient felt freaking sick. The patient wanted to know what's added in the serum of the vaccine and what was injected in her body and wished to know what was added in the vaccine. The reporter reported she nearly died on 11th August 2018. The reporter reported the hospital gave her 4 double doses of 4 different medication which caused her flat lined and reported that particular medication caused her have a heart attack. The reporter reported that her roommate watched her flat line. She felt every electrical bolt run though her body to get her heart stabilize too. The patient heart rate went from 60's to flatline to 28 to 211 beats a minute. The patient was told to have ventricular tachycardia. Lab Comments: The patient heart rate went from 60's to flatline to 28 to 211 beats a minute.
vaccine given to 17 y.o.  when age should have been 18 y.o.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 01-MAY-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056:
Resident s/p Covid 19 Vaccination on 01/19/21.. Resident stated she got 3 small raised areas (2.0L X 2.0W cm) (1.5L X 1.5W cm) (1.0L X 1.0W cm) on Right lower leg and one small raised area (1.0L X 1.0W cm) on left lower leg. She noticed them the next day after the vaccination (1/20/21). Besides, She also noted raised, red, area on the injection site on her right upper arm on  01/27/21. She also stated that she had bad reaction, dry heaving after she had her Flu and Pneumonia vaccine last year. Denied shortness of breath, difficulty breathing, fever, tender, pain upon touch but very itchy and asking any medication.  Wellness Nurse explained resident to keep the area clean and dry, no scratching and to let us know if there is increased redness/ area or skin breakdown.
was given MENQUADFI on 08Sep2022 and 18Oct2022 with no reported adverse event; Initial information received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 17 years old female patient who was given meningococcal A-C-Y-W135 (T Conj) vaccine [Menquadfi] on 08-sep-2022 and 18-oct-2022 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 08-Sep-2022, the patient received a dose 1 of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE  0.25 mL to 2 mL for vaccines or 0.1 mL for TB skin test-0. 5ml o Strength: standard except for Fluzone HD (High dose) (lot U7299AC, expiry: 04-AUG-2024) via intramuscular route in the left deltoid. On 18-Oct-2022 she also received a dose 2 of the same vaccine  (lot U7299AC, expiry date: 04-Aug-202 (Year unspecified) via unknown route in unknown administration site as immunization (extra dose administered; Latency: 1 month 10 days)   Still using product : No  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I21.4 ACUTE NON ST ELEVATION MI 1/7/2023 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/26/2022 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/28/2022 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE I21.4 ACUTE NON ST ELEVATION MI 1/7/2023 ATRIAL FIBRILLATION, UNSPECIFIED J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/26/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/28/2022 ATRIAL FIBRILLATION, UNSPECIFIED I21.4 ACUTE NON ST ELEVATION MI 1/7/2023 ATRIAL FIBRILLATION, UNSPECIFIED J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/26/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/28/2022 ATRIAL FIBRILLATION, UNSPECIFIED I21.4 ACUTE NON ST ELEVATION MI 1/7/2023 ACUTE NON ST ELEVATION MI J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/26/2022 ACUTE NON ST ELEVATION MI J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/28/2022 ACUTE NON ST ELEVATION MI
Large, red, itchy rash at vaccination site. Appeared about 1 week after vaccine.
Administed 0.5ml varicella vaccine 4/11/2023 at 0947am since employee had a negative varicella titer and no proof of previous vaccination. Approximately 0952am on 4/11/2023, patient began complaining of lightheadedness and nausea. 1025am pt began complaining of itching in her throat. All vitals remained WNL during her time at our clinic. PT was never in any distress and no symptoms of anaphylaxis. However, 50mg benadryl given po as a precaution. Pt requested to go the ED downstairs from our employee health clinic within the hospital. EE was wheeled to the ED for treatment approximately 1040am. VS were normal in the ED.  PT declined additional meds (zytrec, prednisone and pepcid) in the ED. The ED discharged patient home with no further complications from the varicella vaccine at this time.
Severe, debilitating headaches 2-3 times a week including nausea, vomiting and double vision. Headaches were at this frequency and intensity until early June.
Large local rxn "size of baseball" p/3rd inject; exposed to a possibly rabid cat; 16JUL91 f/u had same size rxn which lasted 2 days p/inject had been given DPH;
This spontaneous case was initially received on 14-Nov-2015. The case report was received from a(n) Health Professional and concerns a(n) 41 years old male patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 14-Nov-2015, Batch no: T50707, Route of administration: Intramuscular, Dose: 0.5 ml. AFLURIA was stored correctly and the indication for used approved as per the Product Information leaflet. No additional drugs suspected. On an unknown date after starting treatment with AFLURIA the patient experienced Given expired AFLURIA. No adverse reaction was reported due to AFLURIA. The reporter reported the term 'Medication error' and assessed the event as non-serious.
This spontaneous report was received from a physician referring to an unknown number of patients of unknown gender and age. The patients' concomitant medications, pertinent medical history, drug reactions or allergies were not reported. Since 30-MAY-2017 (also reported as since 10-APR-2017), the patients were vaccinated with improperly stored doses of PEDVAXHIB which had the lot # reported as N00236, expiration date 24-OCT-2019, lot # N000235, expiration date 26-OCT-2019, lot # N003536, expiration date 02-NOV-2019, (dosage information and route were not informed). It was reported that the lowest temperature was 32 degrees Fahrenheit and the highest was 54 degrees Fahrenheit for 49 hours. There was no previous temperature excursion. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one case from several cases from the same reporter. Follow-up information has been received from the physician on 16-OCT-2017. Since 29-APR-2017 (also reported as since 10-APR-2017), the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot # M046140, expiration date 27-SEP-2019, dosage information and route were not provided). It was reported that the lowest temperature was 47 degrees Fahrenheit and the highest was 49 degrees Fahrenheit for 16 hours. This is one case from several cases from the same reporter. Follow up information was received from the physician on 16-OCT-2017. The patient was 15 months old. On 13-MAY-2017, the patient was vaccinated with a dose of improperly stored dose of PEDVAXHIB (lot # M046140). The patient's identifiers and the patient's guardian's identifiers were provided. Sender's Comments: US-009507513-1709USA007325.
Female patient who has had previous shingles was administered the Zostavax vaccine and one month later had a shingles outbreak.
This is a spontaneous report received from a contactable consumer, for a Pfizer-sponsored program (159558). An adult male patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), on Mar 4, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed lymphadenopathy/swollen lymph node under his arm and ocular discomfort/his eye feels like there's fluid build-up in tear duct, onset Mar 2021, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information  expected.
vasovagal episode; patient fell from chair 5 min after receiving vaccine, denied any SOB; left asymptomatic after 30 min
Severe projectile vomiting after putting one drop into mouth, would be fussy, vomit, and stop vomiting afterwards. Would still be a bit fussy but calmed easily. No fever, rm temp 72 degrees.
shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a 88-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient's son/daughter. The reporter reported that the shot did not work for his/her father and experienced shingles 3 weeks later. Follow-up would not be possible as no contact details available.
post-COVID vaccination, she had heavy arm and pain, fatigue for more than two days.  She further said she is experiencing a loss of smell and taste, like COVID 19 like symptoms.  No fever during the whole-time post-vaccination until today.
Pain in Rt arm, not relieved by PERCOCET. Occurred 12 hrs hours after injection. Swelling slightly smaller than ping pong ball size. Warm to touch. Pain & swelling at Rt arm pt.
Information has been received from a nurse concerning a female who was vaccinated with the first dose of GARDASIL (lot# Reported as"152X"). Per the nurse, the patient developed a "systemic rash with hives on her face" a week after receiving the first dose of GARDASIL. The patient sought unspecified medical attention by contacting the physician. No further information was provided. Additional information has been requested.
Extreme fatigue about 6 hours after 2nd dose. body/muscle aches, fever, chills, trouble regulating body temp, headache 10 hours until fever broke. Headache and muscle aches/sensitivity the next day.
Had shot, drove to 30 minute lane to watch son for reaction. Within 5 minutes of shot, I started to pass out and called out for help. By the time they had medics come to me and check BP, it was 210/120. I also felt like my whole body was on fire. I could feel it moving through me like fire going throughout my legs -- down to my feet and back up. I had the worst headache I've ever had and was nauseated. The medics had me pull out of the lane to continue to monitor me. After about 30 minutes they said my BP had gone down enough to leave. My son started to dive away. It started all over again and he took me to the hospital closest to where we were going--Hospital. The emergency doctor saw me and gave me an IV with Benadryl, Toradol, and Reglan. I followed up with my doctor on 3/29/21. I had a very bad headache and nausea for at least two weeks and could reproduce the fire-like feeling in my legs for 6 weeks.  The lingering headache finally subsided after about a month or so. The ER doctor, my primary doctor, my pain management doctor, my neurologist, my cardiologist, and my cousin (an infectious disease doctor) all told me to never take the vaccine again.
3-4cm area became red and "stingy" continuing for 3 days.Stayed red for another day.
Fever 5-10min p/immun; vomited x3times; sz to ER quit breathing CPR by Father; Admitted  to Hosp; MD said infect in both ears; Also had cough, bronchopneumonia, lethargic;
Bad local reaction VS beginning cellulitis given script for Benadryl and Keflex.
This spontaneous report as received from a licensed vocational nurse refers to a 1 year old male patient with an unspecified genetic glycogen storage condition. No pertinent medical history was provided. About 2 weeks ago, approximately on 28-JUL-2014, the patient was vaccinated with (Oka/Merck) VARIVAX vial 1350U, 0.5 ml, subcutaneously (lot number not reported). No co-suspect or concomitant therapies were reported. On an unspecified date in 2014, the patient was diagnosed with varicella after receiving (Oka/Merck) VARIVAX. The patient sought medical attention by visiting an unspecified dermatologist. The adverse event was treated with BACTROBAN cream and an unspecified type of steroid treatment. No lab diagnostics studies were performed. At the time of the report, the patient had not recovered from the adverse event. Additional information has been requested.
Bad cold; Sneezing; Coughing; Chest cold; Dull headache; Felt hot; Shaky; Temperature of 102F/ Fever 100F; Body was sore; Queasy; Chills; Tired; A spontaneous report was received from a consumer who's experienced chills, felt hot, temperature of 102F, feeling queasy,shaky, body was sore, and felt tired after vaccination.  There is no patients medical history was provided. No concomitant medications were provided.  On 14-feb-2021   a prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (unknown Lot number) through unknown route in the arm for prophylaxis of COVID-19 infection.   On 14-MAR-2021, she received her second dose at 11 am. By 5pmshe was feeling queasy. She took a Motrin around 5pm. By 8pm, she had chills, felt hot, temperature of 102F, shaky, body was sore, and felt tired  Action taken with mRNA-1273 in response to the events was not applicable as she completed both the doses.  The outcome of events, feeling queasy, chills, felt hot, temperature 102F, shaky, body was sore and felt tired was not resolved.; Reporter's Comments: Based on the current available information which shows a temporal association between the use of the product and the start date of the reported events and excluding any other etiology, a causal relationship with the event cannot be excluded. Nausea, myalgia, headache, fatigue, chills and fever are consistent with the safety profile of the product.
Sudden onset of fever 103.9 with cough, headache, & congestion.
I have been feeling very dizzy; Having shortness of breathe; Head hurts; I am really tired; Feeling ill; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 26-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8736), intramuscular in left arm on 02Jun2021 at 13:30 (at the age of 26-years-old) as 2nd dose, single for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8735), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient did not receive any vaccination 4 weeks prior. On 03Jun2021, patient experienced feeling very dizzy, shortness of breathe, head hurt, really tired, and feeling ill. The patient did not take any treatment for the events. The outcome of the events was not recovered.   Information on Lot/Batch number was available. Additional information has been requested.
pre syncope episode, diaphoretic, dizziness, felt as if he was going to pass out. Evaluated by EMS-Cleared
Pt recvd vax 17AUG92 & fainted following the vax; pt recovered the same day; No further details were provided;
Nausea, extreme body aches, headache, low grade fever (currently 100.5), chills, shakes, diarrhea.
Patient received vaccine evening of 12/8/2021. That night he stated his arm was swollen, it felt tight 'maybe what it feels like if a snake bites you.'  He woke up in a sweat that night. Wednesday morning swelling was down the arm. his blood pressure and heart rate were up. On Wednesday evening his blood pressure was low 98/58 and heart rate back to normal. He states today 12/11/2021 feels better.
My period was due a couple days after the vaccine and I developed cramps and bloating but no period. This went away and two weeks later my period arrived. The second month my period arrived a few days later and irregular from usual.
My entire arm from elbow up was red and swollen. Extremely painful.  It has been a year now and I still cannot bring myself to get the second shot.  I also had all the flu like symptoms and I had alot of ringing in my ears and since then I now have a pulsing in my ear and sometimes dizziness since that shot. It feels like my ear is full sometimes.  It comes and goes.   When my arm is resting I can still feel a dull pain in that arm and also noticed is doesn't have the same range of motion I used to have in it.
1 hour after vaccine, I experienced light headedness. Felt very airy; as if I was walking on clouds. 12 hours after vaccine, I developed body aches, body chills, low grade fever (100).
neck pain and stiffness, body pain (like the flu), very sore at shot, tingling in arm of shot